We are live on ! Find out more
EAM

EULAV Asset Management Portfolio holdings

AUM $3.13B
1-Year Est. Return 23.04%
This Fund
S&P 500
This Quarter Est. Return
+6.26%
1 Year Est. Return
+23.04%
3 Year Est. Return
+90.7%
5 Year Est. Return
+115.08%
10 Year Est. Return
+583.23%
AUM
$2.04B
AUM Growth
+$78.5M
Cap. Flow
-$21.3M
Cap. Flow %
-1.05%
Top 10 Hldgs %
16.88%
Holding
318
New
26
Increased
78
Reduced
63
Closed
17

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$18.2M
2
NVRO
NEVRO CORP.
NVRO
+$7.45M
3
EXAS
Exact Sciences
EXAS
+$6.7M
4
ZEN
ZENDESK INC
ZEN
+$5.02M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.99M

Top Sells

Rank Stock Value
1
VAL
Valspar
VAL
+$12.7M
2
AKAM icon
Akamai
AKAM
+$6.27M
3
SYF icon
Synchrony
SYF
+$5.49M
4
HRL icon
Hormel Foods
HRL
+$5.4M
5
ESRX
Express Scripts Holding Company
ESRX
+$4.27M

Sector Composition

Rank Sector Weight
1 Industrials 19.97%
2 Healthcare 18.77%
3 Technology 17.98%
4 Consumer Discretionary 12.95%
5 Financials 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RNR icon
101
RenaissanceRe
RNR
$13.4B
$6.94M 0.34%
49,900
+2,500
+5% +$351K
PLUS icon
102
ePlus
PLUS
$2.34B
$6.91M 0.34%
186,600
+7,000
+4% +$254K
WWD icon
103
Woodward
WWD
$21.4B
$6.89M 0.34%
102,000
– –
OTEX icon
104
Open Text
OTEX
$6.04B
$6.88M 0.34%
218,000
– –
TMO icon
105
Thermo Fisher Scientific
TMO
$220B
$6.86M 0.34%
39,300
– –
SJI
106
DELISTED
South Jersey Industries, Inc.
SJI
$6.85M 0.34%
200,400
– –
FANG icon
107
Diamondback Energy
FANG
$52.7B
$6.84M 0.34%
77,000
+4,000
+5% +$388K
SNX icon
108
TD Synnex
SNX
$20.2B
$6.81M 0.33%
113,600
– –
DXCM icon
109
DexCom
DXCM
$32B
$6.58M 0.32%
360,000
+28,000
+8% +$517K
HDB icon
110
HDFC Bank
HDB
$121B
$6.57M 0.32%
302,000
– –
PRXL
111
DELISTED
Parexel International Corp
PRXL
$6.56M 0.32%
75,450
-6,700
-8% -$499K
AAPL icon
112
Apple
AAPL
$4.57T
$6.4M 0.31%
177,768
+1,768
+1% +$65.4K
XRAY icon
113
Dentsply Sirona
XRAY
$2.43B
$6.39M 0.31%
98,600
+4,100
+4% +$259K
CHE icon
114
Chemed
CHE
$7.22B
$6.38M 0.31%
31,200
+4,000
+15% +$797K
ICPT
115
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$6.3M 0.31%
52,000
– –
MTN icon
116
Vail Resorts
MTN
$5.3B
$6.08M 0.3%
30,000
-2,000
-6% -$403K
DIS icon
117
Walt Disney
DIS
$181B
$6.06M 0.3%
57,000
-5,000
-8% -$548K
ESL
118
DELISTED
Esterline Technologies
ESL
$5.99M 0.29%
63,200
– –
ELS icon
119
Equity Lifestyle Properties
ELS
$12.6B
$5.91M 0.29%
136,800
– –
P
120
DELISTED
Pandora Media Inc
P
$5.89M 0.29%
660,000
+235,000
+55% +$2.26M
AVGO icon
121
Broadcom
AVGO
$2.04T
$5.83M 0.29%
250,000
– –
INTU icon
122
Intuit
INTU
$89B
$5.82M 0.29%
43,800
– –
RSG icon
123
Republic Services
RSG
$65.7B
$5.81M 0.28%
91,191
+3,691
+4% +$234K
EL icon
124
Estee Lauder
EL
$32B
$5.76M 0.28%
60,000
-5,000
-8% -$459K
SF
125
Stifel
SF
$12.6B
$5.75M 0.28%
281,475
– –
3 4
5
6 7

Similar funds

LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.12B AUM 12.93% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.12B AUM 25.62% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

EULAV Asset Management's Q2 2017 Portfolio in Review

As of Q2 2017, EULAV Asset Management held 318 positions worth $2.04B, up 4% from $1.96B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

EULAV Asset Management's Q2 2017 filing shows 26 new, 78 increased, 63 reduced and 17 closed positions. Its largest new stake was Exact Sciences: 217,000 shares worth $7.67M. The largest sale was Valspar, an estimated $12.7M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.

  • EULAV Asset Management's largest Q2 2017 buy was Exact Sciences: 217,000 shares worth $7.67M.
  • EULAV Asset Management added most to Alexion Pharmaceuticals in Q2 2017, an estimated $18.2M increase.
  • EULAV Asset Management's biggest Q2 2017 reduction was Hormel Foods, cutting an estimated $5.4M.
  • EULAV Asset Management fully exited Valspar in Q2 2017, selling an estimated $12.7M.
  • EULAV Asset Management's ten largest holdings make up 17% of its $2.04B portfolio in Q2 2017.
  • EULAV Asset Management opened 26 new positions and closed 17 in Q2 2017.
  • EULAV Asset Management's portfolio value rose 4% quarter-over-quarter to $2.04B.

Based on EULAV Asset Management's 13F filing for Q2 2017, filed 14 Aug 2017.